Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Origins and outcomes of rheumatoid arthritis

27.08.2004


The origins of rheumatoid arthritis (RA) have been studied with the help of data generated from close to 2000 patients with recent onset RA, who have been followed longitudinally be means of structured surveillance programs in Swedish Rheumatology and coordinated from the Karolinska Institutet and Karolinska University Hospital.



"One interesting finding is that smoking in the context of certain genetic predispositions, increases the risk for rheumatoid arthritis in a dramatic way, i.e. a marked gene-environment interaction is present between genes and environment in RA. The findings reinforce the special need for programs aimed at cessation of smoking in individuals with RA and at risk for RA" says Lars Klareskog, Professor at Karolinska Institutet.

The outcomes of RA, and in particular the results of different treatments have also been studied with the help of longitudinal structured surveillance programs. "Here, we have been able to monitor both effects and adverse effects of conventional as well as novel "biological" therapies against RA in clinical practice. The systems have enabled us to study the prognostic value of immunologic as well as genetic factors, and thereby helped in optimising therapy for the individual patient" says Lars Klareskog.


The system for obtaining the longitudinal structured patient data has been developed together with patients at the Rheumatology Department at Karolinska University Hospital. It does now enable patients to give information of their disease via the computer to a web-based system before meeting the physician, so that both patient and physician at the consultation have access to the relevant graphically displayed data on the longitudinal disease development and the effects of different past therapies.

This system improves the quality in the meeting between the single patient and single physician, and provides at the same time an important tool for the clinical research, which enables the clinical scientist to make full use of the unique potentials that the Swedish health care system and health care data bases provide for understanding origins an outcomes of major chronic diseases.

Pontus Bråmer | alfa
Further information:
http://info.ki.se

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Shrews shrink in winter and regrow in spring

24.10.2017 | Life Sciences

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>